AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25635958 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain in either masseter muscle or TMJ
Number of subjects: 16
Study 25635958 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain measured using visual analog scale and McGill Pain Questionnaire
Number of subjects: 16
Study 23030237 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine collagen matrix (CM)
Number of subjects: 14
Study 23030237 — intervention group
Group type: COMPARATOR
Intervention: Free gingival graft (FGG)
Number of subjects: 14
Study 23030237 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CM and FGG)
Number of subjects: 14
Study 20559303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 2203
Study 20559303 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 2203
Study 18368945 — intervention group
Group type: COMPARATOR
Intervention: Nanopril (test formulation)
Number of subjects: 26
Study 18368945 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 26
Study 17167157 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 59
Study 17167157 — intervention group
Group type: COMPARATOR
Intervention: Toning and stretching control
Number of subjects: 59
Study 12660531 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 0
Study 11259720 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pacing (atriobiventricular pacing)
Number of subjects: 48
Study 9552084 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone injections (n=22)
Number of subjects: 50
Study 9552084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=23)
Number of subjects: 50
Study 7848350 — intervention group
Group type: EXPERIMENTAL
Intervention: Test patch (Deponit 5)
Number of subjects: 0
Study 7848350 — intervention group
Group type: COMPARATOR
Intervention: Reference patch
Number of subjects: 0
Study 3153709 — intervention group
Group type: EXPERIMENTAL
Intervention: oxaprotiline (75, 150, 225 mg/day for 4 weeks)
Number of subjects: 30
Study 3153709 — intervention group
Group type: EXPERIMENTAL
Intervention: doxepin (75, 150, 225 mg/day for 4 weeks)
Number of subjects: 30
Study 3153709 — intervention group
Group type: EXPERIMENTAL
Intervention: doxepin
Number of subjects: 30
Study 3153709 — intervention group
Group type: EXPERIMENTAL
Intervention: oxaprotiline and doxepin
Number of subjects: 30
Study 31486370 — intervention group
Group type: EXPERIMENTAL
Intervention: NBTXR3 plus radiotherapy
Number of subjects: 0
Study 31486370 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 0
Study 27085700 — intervention group
Group type: EXPERIMENTAL
Intervention: Discography with gadobutrol (group DG)
Number of subjects: 30
Study 27085700 — intervention group
Group type: EXPERIMENTAL
Intervention: Discoblock with bupivacaine (group DB)
Number of subjects: 30
Study 27085700 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group C)
Number of subjects: 30
Study 25697965 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized educational materials
Number of subjects: 221
Study 25697965 — intervention group
Group type: COMPARATOR
Intervention: Conventional interventions only
Number of subjects: 221
Study 23238616 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (α-LA) 600 mg intravenous injection daily for 5 days
Number of subjects: 63
Study 23238616 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (saline)
Number of subjects: 63
Study 21842016 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-headed toothbrush (DenTrust)
Number of subjects: 20
Study 21842016 — intervention group
Group type: COMPARATOR
Intervention: Conventional toothbrush (Bitufo 22)
Number of subjects: 20
Study 21842016 — intervention group
Group type: COMPARATOR
Intervention: Dentist
Number of subjects: 20
Study 21842016 — intervention group
Group type: COMPARATOR
Intervention: Mother
Number of subjects: 20
Study 18849890 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 130
Study 18849890 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 130
Study 18849890 — intervention group
Group type: COMPARATOR
Intervention: Atypical antipsychotics (general)
Number of subjects: 130
Study 17081897 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 IU/mL low-molecular-weight heparin (LMWH) in the infusion fluid
Number of subjects: 60
Study 17081897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LMWH)
Number of subjects: 60
Study 15624745 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemodenervation of sweat glands using botulinum toxin type A (BTX‐A)
Number of subjects: 0
Study 11699674 — intervention group
Group type: EXPERIMENTAL
Intervention: A trials (children searched for the object after a 10-s delay)
Number of subjects: 92
Study 11699674 — intervention group
Group type: EXPERIMENTAL
Intervention: A trials followed by B trials (children watched as a toy was hidden at Location B)
Number of subjects: 92
Study 11699674 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated trials to Location B
Number of subjects: 92
Study 11699674 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer trials to Location A
Number of subjects: 92
Study 9253337 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50 mg
Number of subjects: 10
Study 9253337 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 200 mg
Number of subjects: 10
Study 9253337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7959264 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical vulvectomy with bilateral inguinal lymphadenectomy
Number of subjects: 157
Study 7959264 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical hemivulvectomy with selective inguinal lymphadenectomy
Number of subjects: 157
Study 7959264 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 157
Study 30269143 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to altitude (2,590 m) after echocardiography at 490 m.
Number of subjects: 37
Study 30004919 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance every 3 months
Number of subjects: 4463
Study 30004919 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance every 6 months
Number of subjects: 4463
Study 30004919 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual surveillance
Number of subjects: 4463
Study 30004919 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent imaging (monthly)
Number of subjects: 4463
Study 27806902 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 3514
Study 27806902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 3514
Study 27806902 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents
Number of subjects: 3514
Study 24508204 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RAI (n=247)
Number of subjects: 310
Study 24508204 — intervention group
Group type: COMPARATOR
Intervention: Patients without RAI (n=63)
Number of subjects: 310
Study 24508204 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RAI and non-RAI)
Number of subjects: 310
Study 22569841 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Number of subjects: 353
Study 22569841 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil and leucovorin (Control)
Number of subjects: 353
Study 19996069 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with a systolic blood pressure target of <130 mm Hg, using valsartan (160 or 320 mg) plus amlodipine (5 or 10 mg)
Number of subjects: 228
Study 19996069 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with a systolic blood pressure target of <140 mm Hg, using valsartan (160 or 320 mg) plus amlodipine (5 or 10 mg)
Number of subjects: 228
Study 18315978 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom device for measuring dorsal mobility of the first ray of the foot
Number of subjects: 0
Study 18315978 — intervention group
Group type: COMPARATOR
Intervention: Modified Coleman block test
Number of subjects: 0
Study 18315978 — intervention group
Group type: COMPARATOR
Intervention: Klaue device
Number of subjects: 0
Study 18315978 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom device
Number of subjects: 0
Study 15987849 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate supplementation (CaP; 1.0 g elemental calcium)
Number of subjects: 31
Study 12721265 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-247550 at a dose of 6 mg/m2/d administered as a 1-hour intravenous infusion daily for 5 consecutive days every 21 days
Number of subjects: 27
Study 12721265 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-247550 at a dose of 8 mg/m2/d with filgrastim support
Number of subjects: 27
Study 12721265 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-247550 at a dose of 6 mg/m2/d
Number of subjects: 27
Study 10874993 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal breathing flow-volume loops (TBFVL) in healthy newborns
Number of subjects: 113
Study 10874993 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal breathing flow-volume loops (TBFVL) in infants recovering from respiratory diseases
Number of subjects: 113
Study 10874993 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal breathing flow-volume loops (TBFVL) in infants with bronchopulmonary dysplasia (BPD)
Number of subjects: 113
Study 10874993 — intervention group
Group type: COMPARATOR
Intervention: Tidal breathing flow-volume loops (TBFVL) in infants with BPD vs healthy newborns
Number of subjects: 113
Study 10874993 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal breathing flow-volume loops (TBFVL)
Number of subjects: 113
Study 8604366 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic muscle-strength training program (6 sets of 5 maximal contractions, 3 times per week for 8 weeks on a Cybex II dynamometer at 90 degrees per second)
Number of subjects: 20
Study 8604366 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study 2021141 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms Se/d (as selenium-enriched yeast)
Number of subjects: 22
Study 2021141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6184769 — intervention group
Group type: EXPERIMENTAL
Intervention: Red krypton laser photocoagulation
Number of subjects: 68
Study 6184769 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 68
Study 30365918 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA barcoding methodologies for identification of parasitoid wasps
Number of subjects: 0
Study 30365918 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild olives
Number of subjects: 0
Study 30365918 — intervention group
Group type: COMPARATOR
Intervention: Cultivated olives
Number of subjects: 0
Study 30365918 — intervention group
Group type: EXPERIMENTAL
Intervention: Eupelmus spermophilus and Utetes africanus
Number of subjects: 0
Study 30211696 — intervention group
Group type: EXPERIMENTAL
Intervention: 7/10 perceived tightness rating (moderate pressure without pain)
Number of subjects: 120
Study 30211696 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial occlusion pressure
Number of subjects: 120
Study 30211696 — intervention group
Group type: EXPERIMENTAL
Intervention: 10/10 perceived tightness rating (intense pressure with pain)
Number of subjects: 120
Study 30211696 — intervention group
Group type: COMPARATOR
Intervention: Comparison between arterial occlusion pressure and 10/10 condition
Number of subjects: 120
Study 26754752 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (CACB)
Number of subjects: 42
Study 26754752 — intervention group
Group type: COMPARATOR
Intervention: Continuous femoral nerve block (CFNB)
Number of subjects: 42
Study 25491299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal autologous CD34+ BM cell therapy
Number of subjects: 6
Study 22208833 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly spaced education e‐mails with content designed to improve teaching skills (group A)
Number of subjects: 29
Study 22208833 — intervention group
Group type: COMPARATOR
Intervention: No e‐mails (group B)
Number of subjects: 29
Study 20595285 — intervention group
Group type: COMPARATOR
Intervention: Anti-TNF inhibitors (exact type not specified)
Number of subjects: 0
Study 20595285 — intervention group
Group type: EXPERIMENTAL
Intervention: Model based on differences between baseline and last-visit values
Number of subjects: 0
Study 20595285 — intervention group
Group type: EXPERIMENTAL
Intervention: Model based on percentage change from baseline
Number of subjects: 0
Study 17570540 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle exercise at 50 W for 30 min
Number of subjects: 7
Study 17570540 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle exercise at 50 W for 60 min
Number of subjects: 7
Study 17570540 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle exercise at 50 W for 120 min
Number of subjects: 7
Study 17570540 — intervention group
Group type: COMPARATOR
Intervention: Bicycle exercise at 100 W
Number of subjects: 7
Study 17570540 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 7
Study 16148463 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured abstracts
Number of subjects: 56
Study 16148463 — intervention group
Group type: COMPARATOR
Intervention: Unstructured abstracts
Number of subjects: 56
Study 16148463 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstracts published after 1990
Number of subjects: 56
Study 12401639 — intervention group
Group type: EXPERIMENTAL
Intervention: Wendl tube (28 Ch) kept in position during intubation
Number of subjects: 60
Study 12401639 — intervention group
Group type: COMPARATOR
Intervention: Control group (Wendl tube retrieved before intubation)
Number of subjects: 60
Study 10201758 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 50
Study 10201758 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated tonsillar fossa)
Number of subjects: 50
Study 7770402 — intervention group
Group type: COMPARATOR
Intervention: Calcium heparin (0.2 ml-5000 UI if <70 kg or 0.3 ml-7500 IU if ≥70 kg, twice a day)
Number of subjects: 295
Study 2182705 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin (300 mg daily for 2 weeks)
Number of subjects: 12
Study 2182705 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 2 weeks)
Number of subjects: 12
Study 44234 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide diuretic treatment
Number of subjects: 0
Study 44234 — intervention group
Group type: COMPARATOR
Intervention: Other drug treatment
Number of subjects: 0
Study 44234 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-adrenoreceptor-blocking drugs (suggested therapy)
Number of subjects: 0
Study 31470814 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐channeled King Vision VL
Number of subjects: 99
Study 31470814 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath MAC VL
Number of subjects: 99
Study 31470814 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 99
Study 29672935 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawthorn (Crataegus oxyacantha) 160 mg
Number of subjects: 20
Study 29672935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27147610 — intervention group
Group type: EXPERIMENTAL
Intervention: IC adenosine (2-3 mg total)
Number of subjects: 247
Study 27147610 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (500 μg total)
Number of subjects: 247
Study 27147610 — intervention group
Group type: COMPARATOR
Intervention: Control (standard PPCI)
Number of subjects: 247
Study 24599772 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme with leucine supplementation (10 g/day)
Number of subjects: 17
Study 24599772 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 17
Study 22465904 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/d) plus zinc (440 mg/d)
Number of subjects: 23
Study 22465904 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine plus placebo
Number of subjects: 23
Study 19293160 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg once weekly plus methotrexate (MTX)
Number of subjects: 0
Study 19293160 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 0
Study 18035427 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPRODEX Otic Suspension (CIP/DEX) - four drops instilled into each middle ear through tympanostomy tubes
Number of subjects: 25
Study 16101608 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 microg oral misoprostol
Number of subjects: 1229
Study 16101608 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with four 0.5-mg ergometrine tablets
Number of subjects: 1229
Study 12808615 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide in combination with IFN-alpha
Number of subjects: 68
Study 12808615 — intervention group
Group type: COMPARATOR
Intervention: Octreotide alone
Number of subjects: 68
Study 10996770 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-coded duplex ultrasound
Number of subjects: 46
Study 10996770 — intervention group
Group type: COMPARATOR
Intervention: CT angiography (CTA)
Number of subjects: 46
Study 8796157 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 23
Study 8796157 — intervention group
Group type: COMPARATOR
Intervention: Control (no acetazolamide)
Number of subjects: 23
Study 1602956 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol (250 cc intravenous at 20% injected in 1 h)
Number of subjects: 0
Study 1602956 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (intravenous perfusion glucose serum 250 cc with 1 g of vitamins C, 250 mg of vitamin B6 and 1 g of calcium gluconate injected in 1 h)
Number of subjects: 0
Study 3902523 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG) administered intramuscularly, initial dosage of 10,000 IU followed by 5,000 IU twice weekly up to week 12, then once weekly up to week 16
Number of subjects: 32
Study 3902523 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG)
Number of subjects: 32
Study 3902523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31408237 — intervention group
Group type: EXPERIMENTAL
Intervention: NicAlert reading of 1
Number of subjects: 92
Study 31408237 — intervention group
Group type: EXPERIMENTAL
Intervention: NicAlert reading of 2
Number of subjects: 92
Study 31408237 — intervention group
Group type: EXPERIMENTAL
Intervention: NicAlert reading of 3
Number of subjects: 92
Study 28581284 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral phenylephrine 1.5%
Number of subjects: 295
Study 28581284 — intervention group
Group type: COMPARATOR
Intervention: Topical mydriatic
Number of subjects: 295
Study 26642868 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-list retrieval practice
Number of subjects: 0
Study 26642868 — intervention group
Group type: COMPARATOR
Intervention: Extra-list retrieval practice
Number of subjects: 0
Study 24809882 — intervention group
Group type: EXPERIMENTAL
Intervention: Clocortolone pivalate cream 0.1% (Cloderm Cream, Promius Pharma)
Number of subjects: 0
Study 24809882 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyrate lotion
Number of subjects: 0
Study 24809882 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyrate lipocream
Number of subjects: 0
Study 24809882 — intervention group
Group type: COMPARATOR
Intervention: Non-treated damaged control
Number of subjects: 0
Study 24809882 — intervention group
Group type: COMPARATOR
Intervention: Non-treated normal skin
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-9451 60 mg once daily
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-9451 200 mg
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-9451 400 mg
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-9451 200 mg and 400 mg
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: NS3 clinical mutants
Number of subjects: 0
Study 22869562 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-9451
Number of subjects: 0
Study 19383902 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol intervention
Number of subjects: 1891
Study 19383902 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol intervention (highest quintile at baseline)
Number of subjects: 1891
Study 19383902 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol intervention (3-year follow-up measurement)
Number of subjects: 1891
Study 19383902 — intervention group
Group type: COMPARATOR
Intervention: Beta-carotene, serum retinol, and supplemental beta-carotene
Number of subjects: 1891
Study 17479308 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 34
Study 17479308 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 34
Study 15668859 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dalbavancin (1000 mg single dose followed by 500 mg one week later)
Number of subjects: 75
Study 15668859 — intervention group
Group type: COMPARATOR
Intervention: Intravenous vancomycin (administered twice daily for 14 days)
Number of subjects: 75
Study 11886001 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel 35 mg/m2, gemcitabine 800 mg/m2 and cisplatin 35 mg/m2, on days 1 and 8 every 3 weeks
Number of subjects: 35
Study 11886001 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel, gemcitabine and cisplatin
Number of subjects: 35
Study 9704782 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal glucose tolerance
Number of subjects: 16
Study 9704782 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose tolerance
Number of subjects: 16
Study 9704782 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect calorimetry
Number of subjects: 16
Study 9704782 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 16